COVID-19 Testing Laboratory

For Healthcare Providers

OUTSOURCING SAMPLES

Do you need help increasing your COVID-19 testing capacity? Send your swab specimens to our high-throughput capacity CLIA-certified lab and we can provide results in 24 – 48 hours. Results are accessed using a secure portal.

WHO SHOULD GET TESTED

  • Patients experiencing symptoms consistent with COVID-19 (CDC symptoms list)
  • Those in close contact with someone who tested positive for COVID-19
  • Those who had suspected exposure to someone who tested positive for COVID-19
  • Those who plan to travel internationally
  • Those needing to confirm COVID-19 status for a third party (e.g. work, school, visiting a restricted location, etc.)
  • Patients at high risk and who want peace of mind
  • Anyone who just wants to know

COVID-19 PCR ACTIVE INFECTION TEST

Detects the presence of viral RNA with an RT-PCR test using CDC-approved primers for SARS-CoV-2. Recommended for diagnosing active infection with SARS-CoV-2.

ACCEPTED SAMPLES

Nasal swab

SAMPLE COLLECTION

Samples are collected at the healthcare provider office or other designated testing location under the supervision of a healthcare provider, or at the PanoHealth location (additional sample collection fee can apply):
3607 Parkway Lane, Suite 300
Peachtree Corners, GA 30092

Lab technician with COVID-19 nasal swab sample and tube

TURNAROUND TIME

Results are delivered in 24 – 48 hours from the receipt of the sample. Results are delivered electronically to the ordering physician.

GET STARTED WITH PANOHEALTH

Contact Us
First
Last

HAVE A QUESTION?

Contact info@panohealth.com

PanoHealth’s COVID-19 PCR test has not been FDA cleared or approved, has been authorized by FDA under an Emergency Use Authorization (EUA), and has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

PanoHealth | COVID-19 Testing Lab For Providers